Targeting of RET oncogene by naphthalene diimide-mediated gene promoter G-quadruplex stabilization exerts anti-tumor activity in oncogene-addicted human medullary thyroid cancer

SUPPLEMENTARY MATERIALS AND METHODS
Transfection experiments
Transient transfection of RET encoding vectors was carried out according to standard procedures. Briefly, wild-type and MEN2A (C634R)-associated RET pRc/CMVconstructs were obtained as previously described [38] . Twenty-four (MCF-7) or 72 (TT) h after seeding in a 6-well plate, cells (0.3x10 6 cells/well) were transiently transfected with 2.5 μg/well of pRC/ CMV plasmid (Thermo Fisher Scientific, Monza, Italy) encoding wild-type or mutant (C634R) protoRET using Lipofectamine® 3000 (Thermo Fischer Scientific) in standard growth medium containing 10% FBS, according to the manufacturer's protocol. Forty-eight hours after transfection, cells were treated with the NDI derivative for 48 and 96 h at a concentration corresponding to the IC 50 . Cells were then collected, counted in a particle counter and subsequently analysed. 
